NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
Beverly Hills, California., Jan. 10, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it entered into a paying Consultancy Agreement with Orocidin A/S in Denmark.
Related news for (NORD)
- Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for Periodontitis
- Nordicus Partners To Host Investor Relations Webinar on July 10, 2024
- Orocidin – New Insights Into The Treatment Of Periodontitis
- Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
- Nordicus Partners Corporation Engages FORCE Family Office